HomeCompareUBX vs CL

UBX vs CL: Dividend Comparison 2026

UBX yields 999.50% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UBX wins by $18762502.84M in total portfolio value
10 years
UBX
UBX
● Live price
999.50%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18762502.88M
Annual income
$15,677,048,250,727.08
Full UBX calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — UBX vs CL

📍 UBX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUBXCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UBX + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UBX pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UBX
Annual income on $10K today (after 15% tax)
$84,957.52/yr
After 10yr DRIP, annual income (after tax)
$13,325,491,013,118.02/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, UBX beats the other by $13,325,491,008,526.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UBX + CL for your $10,000?

UBX: 50%CL: 50%
100% CL50/50100% UBX
Portfolio after 10yr
$9381251.46M
Annual income
$7,838,524,128,064.52/yr
Blended yield
83.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

UBX
Analyst Ratings
7
Buy
3
Hold
Consensus: Buy
Price Target
$2.50
+1149.4% upside vs current
Range: $1.00 — $4.00
Altman Z
-26.4
Piotroski
2/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UBX buys
0
CL buys
0
No recent congressional trades found for UBX or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUBXCL
Forward yield999.50%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$18762502.88M$40.8K
Annual income after 10y$15,677,048,250,727.08$5,401.96
Total dividends collected$18526733.01M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold
Analyst price target$2.50$92.45

Year-by-year: UBX vs CL ($10,000, DRIP)

YearUBX PortfolioUBX Income/yrCL PortfolioCL Income/yrGap
1← crossover$110,650$99,950.02$11,012$312.01+$99.6KUBX
2$1,151,991$1,033,595.59$12,196$412.95+$1.14MUBX
3$11,289,539$10,056,908.06$13,599$549.66+$11.28MUBX
4$104,190,015$92,110,208.43$15,288$736.64+$104.17MUBX
5$905,946,717$794,463,401.71$17,353$995.28+$905.93MUBX
6$7,425,409,853$6,456,046,865.26$19,926$1,357.80+$7425.39MUBX
7$57,399,102,727$49,453,914,184.22$23,194$1,873.82+$57399.08MUBX
8$418,691,166,930$357,274,127,011.89$27,439$2,621.52+$418691.14MUBX
9$2,883,602,458,699$2,435,602,910,084.79$33,088$3,727.38+$2883602.43MUBX
10$18,762,502,881,535$15,677,048,250,727.08$40,806$5,401.96+$18762502.84MUBX

UBX vs CL: Complete Analysis 2026

UBXStock

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

Full UBX Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this UBX vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UBX vs SCHDUBX vs JEPIUBX vs OUBX vs KOUBX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.